The editorial team at Contact Lens Spectrum is starting to put together summary materials of non-branded, non-promotional educational content that relates to the fitting of all modalities of contact lenses and to lens care. If your organization, society, or association has such educational materials that are publicly available, we would love to hear from you. Please email us at email@example.com to let us know. In addition, we would love a copy of the materials or a link to them.
Jason J. Nichols, OD, MPH, PhD
CooperVision Announces 2019 Patient Rebate Values
CooperVision, Inc. has unveiled the details of its updated patient rebate program, currently effective through June 30, 2019.
The following CooperVision patient rebates are now available: MyDay daily disposable – $130 off of four 180-packs or eight 90-packs; Clariti 1 Day – $200 off of eight 90-packs or 24 30-packs (new to CooperVision only) and $130 off of eight 90-packs or 24 30-packs (current CooperVision wearers); Biofinity Energys – $60 off of four six-packs; Biofinity sphere – $30 off of four six-packs; and Biofinity Toric and Biofinity Multifocal – $50 off of four six-packs. Additional patient rebate terms and conditions apply.
Atlantis Scleral Deep Savings Spare Lens Program
X-Cel Specialty Contacts has updated its Atlantis Spare Lens Program. The program offers Atlantis lenses, in duplicate parameters, at a savings of 40% to 50% off of the standard price when purchased within 90 days of a patient’s final prescription. For added value, the company offers travel-sized, mirrored patient kits that provide a place to store spare lenses. This program is for the continental United States only.
Bruder Introduces Hygienic Eyelid Solution
Bruder Healthcare announces the immediate availability of Bruder Hygienic Eyelid Solution, a 0.2% pure hypochlorous acid solution for daily, long-term use. This solution contains no alcohol, oil, sulfates, parabens, or added fragrance. The company says that the refreshing spray application is soothing to sensitive skin and provides fast relief from dryness and from itchy, inflamed skin. Bruder Hygienic Eyelid Solution is available in two sizes: 1 fluid ounce (30mL) and 2 fluid ounces (60mL).
Alcon Debuts iLux MGD Treatment System
Alcon debuted the iLux MGD Treatment System to the eyecare professional (ECP) community. According to the company, the device, which received clearance from the U.S. Food and Drug Administration in December 2017, helps ECPs provide comprehensive, in-office treatment for their patients who have dry eye disease.
The iLux Device is indicated for the application of localized heat and pressure therapy in adult patients who have chronic disease of the eyelids, including meibomian gland dysfunction (MGD).
Nominations Open for 2019 BCLA Awards
The British Contact Lens Association (BCLA) announced that nominations are now open for the 2019 BCLA Awards. Held as part of this year’s Clinical Conference and Exhibition, the awards will honor those who have a track record for excellence in eye care and a passion for pioneering new techniques that are transforming everyday practice. The three-day conference will be held from May 30 to June 1, 2019.
The BCLA Dry Eye Practitioner of the Year Award will be given to an individual working in practice who has a proven record in managing dry eye. And, the BCLA Young Contact Lens Practitioner Award will be given to an individual working in practice who is just starting out in his or her career. The deadline for both of these categories is April 12.
Additionally, the BCLA Industry Award will be given to an individual working within industry who has made an outstanding contribution to the contact lens profession either in relation to a product/technology or a concept. The deadline for this category is April 5.
Thea Pharmaceuticals Launches Blephademodex Eye Lid Wipes
Thea Pharmaceuticals has extended the Blepha range of lid care products with the launch of Blephademodex Eye Lid Wipes. According to the company, Blephademodex cleans away crusts, eyelash dandruff, impurities, mites, and debris on eyelids and eyelashes that cause eyelid inflammation and improves symptoms linked to Demodex infestation.
Blephademodex has two key active ingredients: terpinen-4-ol, a purified active extract from tea tree oil, which at a low concentration of 2.5% is used for its antimicrobial and anti-inflammatory properties; and sodium hyaluronate, a natural skin soothing and moisturizing agent. The preservative-free Blephademodex is available in boxes of 30 sterile ready-to-use wipes.
Are scleral contact lenses impacting the rate of corneal transplants in your practice?
Even the best-fit scleral lenses cannot always correct residual higher-order aberrations. Practitioners, lens designers, software, and equipment engineers are working together in an effort to address this issue that frustrates patients and professionals alike. Look for significant progress in the future.
We thank Dr. Arnold for this image and welcome photo submissions from our other readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
SPECIALTY LENS SPACE
Karen DeLoss, OD
Contact Lens Options for Myopia
As eyecare providers, we are not "myopic" to the prevalence of myopia. Incidence can depend on geography, with general trends of higher rates in Asian populations. It is estimated that myopia will continue to increase over the next few decades.1 Myopia has been linked to genetic factors, such as parents who have myopia. Environmental factors, such as near work and reading, can additionally play a role in myopia. Myopia is also more common in urban areas, with higher rates among professionals, with higher levels of education, and with high computer use.2 Thus, it is no surprise that a huge amount of effort is invested into controlling myopia. Of the tools available, contact lenses demonstrate some promise.
Studies using multifocal contact lenses have demonstrated promising results in terms of overall slowing of myopia and also reducing axial length. Mostly distance-center, concentric alternating areas of distance and near powers have shown promise.3,4 Orthokeratology, which both flattens the cornea, helping to control axial length by redirecting light rays hitting the peripheral retina, has been widely studied. Both modalities have been shown to control myopia progression by 40% and axial elongation by up to 50% compared to traditional single-vision modalities.3,4 Thus, contact lens options may be worth exploring in young myopic patients.
1. Holden, BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016 May;123:1036-1042.
2. Cooper J, Tkatchenko AV. A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye Contact Lens. 2018 Jul;44:231-247.
3. Chamberlain P, Back A, Lazon P, et al. 3 year effectiveness of a dual-focus 1-day soft contact lens for myopia control. Contact Lens Anterior Eye. 2018 Jun;41:S71-S72.
4. Saw, SM, Matsumura S, Hoang, QV. Prevention and Management of Myopia and Myopic Pathology. Invest Ophthalmol Vis Sci. 2019 Feb 1;60:488-499.
MATERIALS & DESIGNS
David L. Kading, OD
New, New, New
The following statement does not seem like news anymore: "A new lens was released by XYZ company, and executive ABC claims that the improvement seen in research will positively affect patients’ lives." Admit it, you have received these press releases and have seen them regularly published in our journals. At present, nearly every company has completed the family for its lenses (yes, exceptions exist, and that press release will probably come out tomorrow). Is this news exciting and impactful anymore?
As I travel the world talking about contact lenses, I enjoy asking practitioners about their prescribing habits. What I tend to discover is an approach to lens fitting along the lines of: If it ain’t broke, don’t fix it (i.e., once patients have a problem in this lens, we will consider moving them). I understand this from a practice management/patient flow standpoint. Why shift something and require a follow up or the potential for additional visits? However—pushing the practice management side of things aside—if we wait until something breaks, it may be harder to fix.
In reality, if patients become uncomfortable with a long-standing lens, it is because of damage to the ocular surface, not because the contact lens changed. I would encourage you to look at your prescribing habits and ask: Am I pushing toward better health and a more improved lens?
I personally believe that the best avenue for this is with daily disposable lenses. Once you start seeing the innovations as an opportunity to save vision and comfort, "new, new, new" will become exciting all over again.
Diversity of Ocular Surface Bacterial Microbiome Adherent to Worn Contact Lenses and Bacterial Communities Associated With Care Solution Use
The purpose of this study was to assess the microbiome adherent to contact lenses and to define the bacterial communities associated with the use of lens care solutions.
Among 84 lenses screened for an adherent ocular surface bacterial microbiome using 16S rRNA molecular amplification, 63 (75%) generated bacterial-specific amplicons processed using the Ion Torrent Personal Genome Machine workflow. Data were stratified by solution use (peroxide versus polyhexamethylene biguanide [PHMB]-preserved multipurpose solution [MPS]). Diversity of the lens-adherent microbiome was characterized using the Shannon diversity index and richness index. Data were analyzed using principal components analysis and Kruskal-Wallis tests.
The authors identified 19 phyla and 167 genera of bacteria adherent to the lenses. Proteobacteria was the most abundant phyla, followed by Firmicutes and Actinobacteria. The most abundant bacterial genera (> 1% abundance) were Ralstonia, Enterococcus, Streptococcus, Halomonas, Corynebacterium, Staphylococcus, Acinetobacter, Shewanella, Rhodococcus, and Cobetia. Sixteen of 20 lenses (80%) that were negative for bacterial DNA were worn by participants using peroxide solutions, while only four (20%) were MPS-treated lenses (P = 0.004). Genera diversity of the lens-adherent microbiome was significantly increased in MPS-treated lenses compared with peroxide (P = 0.038). Abundance of Corynebacterium, Haemophilus, and Streptococcus were increased 4.3-, 12.3-, and 2.7-fold, respectively, in the MPS group compared with peroxide (P = 0.014, 0.006, and 0.047, respectively).
The researchers concluded that commensal, environmental, and pathogenic bacteria known to be present in the conjunctival microbiome can be detected on worn contact lenses. Although most contact lenses worn by asymptomatic wearers harbor bacterial DNA, compared with peroxide, lenses stored in a PHMB-preserved MPS have more quantifiable, abundant, and diverse bacterial communities adhered to them.
Retuerto MA, Szczotka-Flynn L, Mukherjee PK, et al. Diversity of Ocular Surface Bacterial Microbiome Adherent to Worn Contact Lenses and Bacterial Communities Associated With Care Solution Use. Eye Contact Lens. 2019 Feb 1. [Epub ahead of print]